 | • レポートコード：GIR-107A12094 • 出版社/出版日：GlobalInfoResearch / 2021年7月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、生物製剤医薬品開発のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。生物製剤医薬品開発の種類別市場規模（臨床製造、製剤開発、バイオアッセイ開発、分析サービス）、用途別市場規模（社内、外部委託、製薬会社）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・生物製剤医薬品開発の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Abbvie、Allergan、Boehringer Ingelheim、Charles River Laboratories、Catalent、Lonza Group、Amgen、Sanofi ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：臨床製造、製剤開発、バイオアッセイ開発、分析サービス ・用途別分析2016年-2026年：社内、外部委託、製薬会社 ・生物製剤医薬品開発の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・生物製剤医薬品開発のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・生物製剤医薬品開発のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・生物製剤医薬品開発の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・生物製剤医薬品開発の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Biologics Drug Development market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Biologics Drug Development size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Biologics Drug Development market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Biologics Drug Development market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Clinical Manufacturing
Formulation Development
Bioassay Development
Analytical Services
Market segment by Application, can be divided into
In-House
Outsource
Pharma Excess
Market segment by players, this report covers
Abbvie
Allergan
Boehringer Ingelheim
Charles River Laboratories
Catalent
Lonza Group
Amgen
Sanofi
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Biologics Drug Development
1.2 Classification of Biologics Drug Development by Type
1.2.1 Overview: Global Biologics Drug Development Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Biologics Drug Development Revenue Market Share by Type in 2020
1.2.3 Clinical Manufacturing
1.2.4 Formulation Development
1.2.5 Bioassay Development
1.2.6 Analytical Services
1.3 Global Biologics Drug Development Market by Application
1.3.1 Overview: Global Biologics Drug Development Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 In-House
1.3.3 Outsource
1.3.4 Pharma Excess
1.4 Global Biologics Drug Development Market Size & Forecast
1.5 Global Biologics Drug Development Market Size and Forecast by Region
1.5.1 Global Biologics Drug Development Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Biologics Drug Development Market Size by Region, (2016-2021)
1.5.3 North America Biologics Drug Development Market Size and Prospect (2016-2026)
1.5.4 Europe Biologics Drug Development Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Biologics Drug Development Market Size and Prospect (2016-2026)
1.5.6 South America Biologics Drug Development Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Biologics Drug Development Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Biologics Drug Development Market Drivers
1.6.2 Biologics Drug Development Market Restraints
1.6.3 Biologics Drug Development Trends Analysis
2 Company Profiles
2.1 Abbvie
2.1.1 Abbvie Details
2.1.2 Abbvie Major Business
2.1.3 Abbvie Biologics Drug Development Product and Solutions
2.1.4 Abbvie Biologics Drug Development Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Abbvie Recent Developments and Future Plans
2.2 Allergan
2.2.1 Allergan Details
2.2.2 Allergan Major Business
2.2.3 Allergan Biologics Drug Development Product and Solutions
2.2.4 Allergan Biologics Drug Development Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Allergan Recent Developments and Future Plans
2.3 Boehringer Ingelheim
2.3.1 Boehringer Ingelheim Details
2.3.2 Boehringer Ingelheim Major Business
2.3.3 Boehringer Ingelheim Biologics Drug Development Product and Solutions
2.3.4 Boehringer Ingelheim Biologics Drug Development Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Boehringer Ingelheim Recent Developments and Future Plans
2.4 Charles River Laboratories
2.4.1 Charles River Laboratories Details
2.4.2 Charles River Laboratories Major Business
2.4.3 Charles River Laboratories Biologics Drug Development Product and Solutions
2.4.4 Charles River Laboratories Biologics Drug Development Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Charles River Laboratories Recent Developments and Future Plans
2.5 Catalent
2.5.1 Catalent Details
2.5.2 Catalent Major Business
2.5.3 Catalent Biologics Drug Development Product and Solutions
2.5.4 Catalent Biologics Drug Development Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Catalent Recent Developments and Future Plans
2.6 Lonza Group
2.6.1 Lonza Group Details
2.6.2 Lonza Group Major Business
2.6.3 Lonza Group Biologics Drug Development Product and Solutions
2.6.4 Lonza Group Biologics Drug Development Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Lonza Group Recent Developments and Future Plans
2.7 Amgen
2.7.1 Amgen Details
2.7.2 Amgen Major Business
2.7.3 Amgen Biologics Drug Development Product and Solutions
2.7.4 Amgen Biologics Drug Development Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Amgen Recent Developments and Future Plans
2.8 Sanofi
2.8.1 Sanofi Details
2.8.2 Sanofi Major Business
2.8.3 Sanofi Biologics Drug Development Product and Solutions
2.8.4 Sanofi Biologics Drug Development Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Sanofi Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Biologics Drug Development Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Biologics Drug Development Players Market Share
3.2.2 Top 10 Biologics Drug Development Players Market Share
3.2.3 Market Competition Trend
3.3 Biologics Drug Development Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Biologics Drug Development Revenue and Market Share by Type (2016-2021)
4.2 Global Biologics Drug Development Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Biologics Drug Development Revenue Market Share by Application (2016-2021)
5.2 Biologics Drug Development Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Biologics Drug Development Revenue by Type (2016-2026)
6.2 North America Biologics Drug Development Revenue by Application (2016-2026)
6.3 North America Biologics Drug Development Market Size by Country
6.3.1 North America Biologics Drug Development Revenue by Country (2016-2026)
6.3.2 United States Biologics Drug Development Market Size and Forecast (2016-2026)
6.3.3 Canada Biologics Drug Development Market Size and Forecast (2016-2026)
6.3.4 Mexico Biologics Drug Development Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Biologics Drug Development Revenue by Type (2016-2026)
7.2 Europe Biologics Drug Development Revenue by Application (2016-2026)
7.3 Europe Biologics Drug Development Market Size by Country
7.3.1 Europe Biologics Drug Development Revenue by Country (2016-2026)
7.3.2 Germany Biologics Drug Development Market Size and Forecast (2016-2026)
7.3.3 France Biologics Drug Development Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Biologics Drug Development Market Size and Forecast (2016-2026)
7.3.5 Russia Biologics Drug Development Market Size and Forecast (2016-2026)
7.3.6 Italy Biologics Drug Development Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Biologics Drug Development Revenue by Type (2016-2026)
8.2 Asia-Pacific Biologics Drug Development Revenue by Application (2016-2026)
8.3 Asia-Pacific Biologics Drug Development Market Size by Region
8.3.1 Asia-Pacific Biologics Drug Development Revenue by Region (2016-2026)
8.3.2 China Biologics Drug Development Market Size and Forecast (2016-2026)
8.3.3 Japan Biologics Drug Development Market Size and Forecast (2016-2026)
8.3.4 South Korea Biologics Drug Development Market Size and Forecast (2016-2026)
8.3.5 India Biologics Drug Development Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Biologics Drug Development Market Size and Forecast (2016-2026)
8.3.7 Australia Biologics Drug Development Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Biologics Drug Development Revenue by Type (2016-2026)
9.2 South America Biologics Drug Development Revenue by Application (2016-2026)
9.3 South America Biologics Drug Development Market Size by Country
9.3.1 South America Biologics Drug Development Revenue by Country (2016-2026)
9.3.2 Brazil Biologics Drug Development Market Size and Forecast (2016-2026)
9.3.3 Argentina Biologics Drug Development Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Biologics Drug Development Revenue by Type (2016-2026)
10.2 Middle East & Africa Biologics Drug Development Revenue by Application (2016-2026)
10.3 Middle East & Africa Biologics Drug Development Market Size by Country
10.3.1 Middle East & Africa Biologics Drug Development Revenue by Country (2016-2026)
10.3.2 Turkey Biologics Drug Development Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Biologics Drug Development Market Size and Forecast (2016-2026)
10.3.4 UAE Biologics Drug Development Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Biologics Drug Development Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Biologics Drug Development Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Biologics Drug Development Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Biologics Drug Development Revenue (USD Million) by Region (2016-2021)
Table 5. Global Biologics Drug Development Revenue Market Share by Region (2021-2026)
Table 6. Abbvie Corporate Information, Head Office, and Major Competitors
Table 7. Abbvie Major Business
Table 8. Abbvie Biologics Drug Development Product and Solutions
Table 9. Abbvie Biologics Drug Development Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Allergan Corporate Information, Head Office, and Major Competitors
Table 11. Allergan Major Business
Table 12. Allergan Biologics Drug Development Product and Solutions
Table 13. Allergan Biologics Drug Development Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Boehringer Ingelheim Corporate Information, Head Office, and Major Competitors
Table 15. Boehringer Ingelheim Major Business
Table 16. Boehringer Ingelheim Biologics Drug Development Product and Solutions
Table 17. Boehringer Ingelheim Biologics Drug Development Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Charles River Laboratories Corporate Information, Head Office, and Major Competitors
Table 19. Charles River Laboratories Major Business
Table 20. Charles River Laboratories Biologics Drug Development Product and Solutions
Table 21. Charles River Laboratories Biologics Drug Development Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Catalent Corporate Information, Head Office, and Major Competitors
Table 23. Catalent Major Business
Table 24. Catalent Biologics Drug Development Product and Solutions
Table 25. Catalent Biologics Drug Development Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Lonza Group Corporate Information, Head Office, and Major Competitors
Table 27. Lonza Group Major Business
Table 28. Lonza Group Biologics Drug Development Product and Solutions
Table 29. Lonza Group Biologics Drug Development Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Amgen Corporate Information, Head Office, and Major Competitors
Table 31. Amgen Major Business
Table 32. Amgen Biologics Drug Development Product and Solutions
Table 33. Amgen Biologics Drug Development Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Sanofi Corporate Information, Head Office, and Major Competitors
Table 35. Sanofi Major Business
Table 36. Sanofi Biologics Drug Development Product and Solutions
Table 37. Sanofi Biologics Drug Development Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Global Biologics Drug Development Revenue (USD Million) by Players (2019-2021)
Table 39. Global Biologics Drug Development Revenue Share by Players (2019-2021)
Table 40. Breakdown of Biologics Drug Development by Company Type (Tier 1, Tier 2 and Tier 3)
Table 41. Biologics Drug Development Players Head Office, Products and Services Provided
Table 42. Biologics Drug Development Mergers & Acquisitions in the Past Five Years
Table 43. Biologics Drug Development New Entrants and Expansion Plans
Table 44. Global Biologics Drug Development Revenue (USD Million) by Type (2016-2021)
Table 45. Global Biologics Drug Development Revenue Share by Type (2016-2021)
Table 46. Global Biologics Drug Development Revenue Forecast by Type (2021-2026)
Table 47. Global Biologics Drug Development Revenue by Application (2016-2021)
Table 48. Global Biologics Drug Development Revenue Forecast by Application (2021-2026)
Table 49. North America Biologics Drug Development Revenue by Type (2016-2021) & (USD Million)
Table 50. North America Biologics Drug Development Revenue by Type (2021-2026) & (USD Million)
Table 51. North America Biologics Drug Development Revenue by Application (2016-2021) & (USD Million)
Table 52. North America Biologics Drug Development Revenue by Application (2021-2026) & (USD Million)
Table 53. North America Biologics Drug Development Revenue by Country (2016-2021) & (USD Million)
Table 54. North America Biologics Drug Development Revenue by Country (2021-2026) & (USD Million)
Table 55. Europe Biologics Drug Development Revenue by Type (2016-2021) & (USD Million)
Table 56. Europe Biologics Drug Development Revenue by Type (2021-2026) & (USD Million)
Table 57. Europe Biologics Drug Development Revenue by Application (2016-2021) & (USD Million)
Table 58. Europe Biologics Drug Development Revenue by Application (2021-2026) & (USD Million)
Table 59. Europe Biologics Drug Development Revenue by Country (2016-2021) & (USD Million)
Table 60. Europe Biologics Drug Development Revenue by Country (2021-2026) & (USD Million)
Table 61. Asia-Pacific Biologics Drug Development Revenue by Type (2016-2021) & (USD Million)
Table 62. Asia-Pacific Biologics Drug Development Revenue by Type (2021-2026) & (USD Million)
Table 63. Asia-Pacific Biologics Drug Development Revenue by Application (2016-2021) & (USD Million)
Table 64. Asia-Pacific Biologics Drug Development Revenue by Application (2021-2026) & (USD Million)
Table 65. Asia-Pacific Biologics Drug Development Revenue by Region (2016-2021) & (USD Million)
Table 66. Asia-Pacific Biologics Drug Development Revenue by Region (2021-2026) & (USD Million)
Table 67. South America Biologics Drug Development Revenue by Type (2016-2021) & (USD Million)
Table 68. South America Biologics Drug Development Revenue by Type (2021-2026) & (USD Million)
Table 69. South America Biologics Drug Development Revenue by Application (2016-2021) & (USD Million)
Table 70. South America Biologics Drug Development Revenue by Application (2021-2026) & (USD Million)
Table 71. South America Biologics Drug Development Revenue by Country (2016-2021) & (USD Million)
Table 72. South America Biologics Drug Development Revenue by Country (2021-2026) & (USD Million)
Table 73. Middle East & Africa Biologics Drug Development Revenue by Type (2016-2021) & (USD Million)
Table 74. Middle East & Africa Biologics Drug Development Revenue by Type (2021-2026) & (USD Million)
Table 75. Middle East & Africa Biologics Drug Development Revenue by Application (2016-2021) & (USD Million)
Table 76. Middle East & Africa Biologics Drug Development Revenue by Application (2021-2026) & (USD Million)
Table 77. Middle East & Africa Biologics Drug Development Revenue by Country (2016-2021) & (USD Million)
Table 78. Middle East & Africa Biologics Drug Development Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Biologics Drug Development Picture
Figure 2. Global Biologics Drug Development Revenue Market Share by Type in 2020
Figure 3. Clinical Manufacturing
Figure 4. Formulation Development
Figure 5. Bioassay Development
Figure 6. Analytical Services
Figure 7. Biologics Drug Development Revenue Market Share by Application in 2020
Figure 8. In-House Picture
Figure 9. Outsource Picture
Figure 10. Pharma Excess Picture
Figure 11. Global Biologics Drug Development Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Biologics Drug Development Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Biologics Drug Development Revenue Market Share by Region (2016-2026)
Figure 14. Global Biologics Drug Development Revenue Market Share by Region in 2020
Figure 15. North America Biologics Drug Development Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Biologics Drug Development Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Biologics Drug Development Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Biologics Drug Development Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Middle East and Africa Biologics Drug Development Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Biologics Drug Development Market Drivers
Figure 21. Biologics Drug Development Market Restraints
Figure 22. Biologics Drug Development Market Trends
Figure 23. Abbvie Recent Developments and Future Plans
Figure 24. Allergan Recent Developments and Future Plans
Figure 25. Boehringer Ingelheim Recent Developments and Future Plans
Figure 26. Charles River Laboratories Recent Developments and Future Plans
Figure 27. Catalent Recent Developments and Future Plans
Figure 28. Lonza Group Recent Developments and Future Plans
Figure 29. Amgen Recent Developments and Future Plans
Figure 30. Sanofi Recent Developments and Future Plans
Figure 31. Global Biologics Drug Development Revenue Share by Players in 2020
Figure 32. Biologics Drug Development Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 33. Global Top 3 Players Biologics Drug Development Revenue Market Share in 2020
Figure 34. Global Top 10 Players Biologics Drug Development Revenue Market Share in 2020
Figure 35. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 36. Global Biologics Drug Development Revenue Share by Type in 2020
Figure 37. Global Biologics Drug Development Market Share Forecast by Type (2021-2026)
Figure 38. Global Biologics Drug Development Revenue Share by Application in 2020
Figure 39. Global Biologics Drug Development Market Share Forecast by Application (2021-2026)
Figure 40. North America Biologics Drug Development Sales Market Share by Type (2016-2026)
Figure 41. North America Biologics Drug Development Sales Market Share by Application (2016-2026)
Figure 42. North America Biologics Drug Development Revenue Market Share by Country (2016-2026)
Figure 43. United States Biologics Drug Development Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Canada Biologics Drug Development Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Mexico Biologics Drug Development Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Europe Biologics Drug Development Sales Market Share by Type (2016-2026)
Figure 47. Europe Biologics Drug Development Sales Market Share by Application (2016-2026)
Figure 48. Europe Biologics Drug Development Revenue Market Share by Country (2016-2026)
Figure 49. Germany Biologics Drug Development Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. France Biologics Drug Development Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. United Kingdom Biologics Drug Development Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Russia Biologics Drug Development Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Italy Biologics Drug Development Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Asia-Pacific Biologics Drug Development Sales Market Share by Type (2016-2026)
Figure 55. Asia-Pacific Biologics Drug Development Sales Market Share by Application (2016-2026)
Figure 56. Asia-Pacific Biologics Drug Development Revenue Market Share by Region (2016-2026)
Figure 57. China Biologics Drug Development Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Japan Biologics Drug Development Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. South Korea Biologics Drug Development Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. India Biologics Drug Development Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Southeast Asia Biologics Drug Development Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Australia Biologics Drug Development Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. South America Biologics Drug Development Sales Market Share by Type (2016-2026)
Figure 64. South America Biologics Drug Development Sales Market Share by Application (2016-2026)
Figure 65. South America Biologics Drug Development Revenue Market Share by Country (2016-2026)
Figure 66. Brazil Biologics Drug Development Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Argentina Biologics Drug Development Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Middle East and Africa Biologics Drug Development Sales Market Share by Type (2016-2026)
Figure 69. Middle East and Africa Biologics Drug Development Sales Market Share by Application (2016-2026)
Figure 70. Middle East and Africa Biologics Drug Development Revenue Market Share by Country (2016-2026)
Figure 71. Turkey Biologics Drug Development Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Saudi Arabia Biologics Drug Development Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. UAE Biologics Drug Development Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Methodology
Figure 75. Research Process and Data Source